Juan Felipe Betancur

Juan Felipe Betancur

Auto-generated profile, based on publicly available information

Juan Felipe Betancur

Centro de Investigaciones Clínicas SURA, Clinical Research Department, Clínica Medellín QuirónSalud, Medellín, Colombia

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2016 in Lupus
Verified
Journal Article
Closed access
JBJ F Betancur
J F Betancur
FBF Bonilla-Abadía
F Bonilla-Abadía
AHA A Hormaza
A A Hormaza
FJF J Jaramillo
F J Jaramillo
CCC A Cañas
C A Cañas
GTG J Tobón
G J Tobón
Aim: The aim of this study was to describe a case series of patients with primary or secondary antiphospholipid syndrome (APS) treated with direct oral anticoagulants (DOACs). Patients and methods: Clinical charts of eight patients with thrombotic primary or secondary APS treated with direct oral anticoagulants (DOACs) between January 2012 and May 2015 were reviewed. Results: The mean age was 45 ± 14.36 (range 27–69 years). Four patients had secondary APS (50%). All patients were initially treated with warfarin by a mean time of 70.87 ± 57.32 months (range 17–153 months). Changes in anticoagulation were defined by recurring thrombosis in five patients (62.5%) and life-threatening bleeding in the other three cases. Seven patients (87.5%) received rivaroxaban treatment and one patient (12.5%) apixaban. The mean follow-up period with DOACs was 19 ± 10.06 months (range 2–36 months). There was no recurrence of thrombosis by the time of data collection. Conclusions: Despite not being the standard treatment in APS, we propose DOACs as a rational alternative for the management of patients with this diagnosis. Further interventional clinical studies are necessary for possible standardization of this therapy in APS patients.

4 February 2021 in BMJ Case Reports
Verified
Journal Article
Open access
PDF file
CAChristian David Adams
Christian David Adams
DSDaniel Syro
Daniel Syro
JLJuan Felipe Llano
Juan Felipe Llano
JBJuan Felipe Betancur
Juan Felipe Betancur
Gadolinium cardiac MRI (CMRI) showed normal cardiac chamber size, preserved right ventricular ejection fraction and left ventricular systolic function in the lower limit (52%), with diffuse hypokinesis. Pericardial effusion and changes in pericardial thickness were absent. There were findings compatible with myocarditis in the tissue characterisation and gadolinium enhancement sequences (figures 1, 2A and B). The evolution of the patient was uneventful, and he recovered completely.

25 April 2022 in Radiology Case Reports
Verified
Journal Article
Open access
JBJuan Felipe Betancur
Juan Felipe Betancur
JGJosé A Gómez-Puerta
José A Gómez-Puerta
JLJuan Felipe Llano
Juan Felipe Llano
GLGustavo Adolfo Lopéz-Ochoa
Gustavo Adolfo Lopéz-Ochoa
BRBeatriz Ramirez
Beatriz Ramirez
OMOscar David Martinez
Oscar David Martinez
Bilateral symmetric striatopallidal calcinosis with or without deposits in dentate nucleus, thalamus, and white matter is reported in patients ranging from asymptomatic, metabolic, toxic, and genetic autosomal dominant, familial or sporadic forms. Of the connective tissue diseases, it has been reported in very few cases in patients with systemic lupus erythematosus, many incorrectly labeled as Fahr syndrome without even having hypoparathyroidism. Here we describe a 30-year-old female patient with neuropsychiatric systemic lupus erythematosus manifested at diagnosis with mood disorders and anxiety, and 1-year later develops Lupus headache; Incidentally, an aneurism of the right middle cerebral artery and bilateral and symmetric calcifications of the caudate and lenticular nuclei were noted; this finding is a rarely reported manifestation of neuropsychiatric systemic lupus erythematosus.

10 September 2024 in Radiology Case Reports
Verified
Journal Article
Open access
JBJuan Felipe Betancur
Juan Felipe Betancur
MGMelina González Diaz Granados
Melina González Diaz Granados
NTNancy Toro
Nancy Toro
JQJulian Quiceno
Julian Quiceno
CECharles Johan Saldarriaga Espinosa
Charles Johan Saldarriaga Espinosa
GMGustavo Matute
Gustavo Matute
Ketamine, a dissociative anesthetic drug, has gained popularity as a recreational substance, particularly among young adults. However, chronic ketamine abuse can lead to various complications including ketamine-induced cystitis. We present the case of a 46-year-old Caucasian male with a history of HIV infection and daily recreational ketamine use for 7 months, who was admitted to the emergency room with hypogastric pain and hematuria. Laboratory examinations and contrast-enhanced abdominal CT tomography revealed significant irregular circumferential thickening of both ureters, substantial bilateral pyeloureteral ectasia, and a bladder with markedly thickened walls. Bilateral flexible ureteropyeloscopy, bladder transurethral resection, and bladder fulguration were performed, and pathology confirmed the diagnosis of ketamine-induced cystitis. Treatment consisted of ketamine withdrawal, pain relief, and support from psychiatrists and urologists. The patient's symptoms improved and he was discharged without complications. This case highlights the importance of recognizing the potential adverse effects of recreational ketamine use and the need for a multidisciplinary approach to managing ketamine-induced cystitis. Further research is necessary to elucidate the precise mechanisms underlying this condition and develop effective prevention and treatment strategies.

20 June 2024 in Archives of Osteoporosis
Verified
Journal Article
Closed access
PDF file
JBJuan Felipe Betancur
Juan Felipe Betancur
LPLuz Eugenia Pérez
Luz Eugenia Pérez
JBJhon Edwar Bolaños-López
Jhon Edwar Bolaños-López
VBVerónica Bernal
Verónica Bernal

28 September 2022 in Radiology Case Reports
Verified
Journal Article
Open access
JBJuan Felipe Betancur
Juan Felipe Betancur
CAChristian Adams-Sánchez
Christian Adams-Sánchez
LRLina Restrepo-Giraldo
Lina Restrepo-Giraldo
JAJoel Arévalo-Novoa
Joel Arévalo-Novoa
BRBeatriz Ramírez
Beatriz Ramírez
GLGustavo Adolfo López
Gustavo Adolfo López
Parathyroid hormone (PTH) has direct and indirect actions on cardiovascular cells. The effects of chronic hypoparathyroidism on cardiac morphology, function, and conduction are still unclear. Low PTH states are associated with multiple manifestations in the heart, acute or chronic. Acute hypocalcemic cardiomyopathy is a transient dilated cardiomyopathy with reduced ejection fraction and diffuse left ventricular hypokinesia. Chronic hypoparathyroidism-associated cardiomyopathy is a rare disease that may cause reduced myocardial tension, cardiac cavity enlargement, arrhythmias, and congestive heart failure. Here, we describe a 73-year-old woman with chronic hypoparathyroidism and hypocalcemia, who developed a hypertrophic cardiomyopathy, and not a dilated hypocalcemia-associated cardiomyopathy, which would be usually the case.